Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-20 Purchase | 2024-08-22 4:30 pm | NewAmsterdam Pharma Co N.V. | NAMS | Davidson Michael H. Chief Executive Officer | 5,000 | $16.27 | $81,350 | 818,563 (Indirect Direct) | View |
| 2024-08-08 Purchase | 2024-08-08 7:42 pm | TENAX THERAPEUTICS INC. | TENX | Davidson Michael H. Director | 2,500 | $0 | $0 | 75,389 (Direct) | View |
| 2024-06-20 Purchase | 2024-06-24 08:30 am | NewAmsterdam Pharma Co N.V. | NAMS | Davidson Michael H. Chief Executive Officer | 5,000 | $17.26 | $86,309 | 813,563 (Indirect Direct) | View |
| 2020-09-09 Purchase | 2020-09-10 4:01 pm | CALADRIUS BIOSCIENCES INC. | CLBS | Davidson Michael H. Director | 55,525 | $1.8 | $99,945 | 106,588 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-09 Gift | 2024-10-11 5:01 pm | 2022-12-22 2027-11-23 | NewAmsterdam Pharma Co N.V. | NAMS | Davidson Michael H. Chief Executive Officer | 15,000 | $11.5 | 85,000 (Direct) | View |
| 2024-09-25 Option Award | 2024-09-27 4:20 pm | N/A 2034-09-24 | BioAge Labs Inc. | BIOA | Davidson Michael H. Director | 48,986 | $0 | 48,986 (Direct) | View |
Ownership | 2024-09-25 4:51 pm | N/A 2034-03-25 | BioAge Labs Inc. | BIOA | Davidson Michael H. Director | 0 | $0 | 33,986 (Direct) | View |
Ownership(A) | 2024-01-25 5:00 pm | 2022-12-22 2027-11-23 | NewAmsterdam Pharma Co N.V. | NAMS | Davidson Michael H. Chief Executive Officer | 0 | $0 | 100,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:14 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Davidson Michael H. Chief Executive Officer | 1,039,939 | $0 | 1,039,939 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A N/A | NewAmsterdam Pharma Co N.V. | NAMS | Davidson Michael H. Chief Executive Officer | 0 | $0 | 5,259,853 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 8:45 pm | 2023-06-09 2032-06-09 | TENAX THERAPEUTICS INC. | TENX | Davidson Michael H. Director | 5,000 | $0 | 619,895 (Direct) | View |
| 2022-01-10 Option Award | 2022-01-12 4:09 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Davidson Michael H. Director | 65,430 | $0 | 209,753 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-15 4:34 pm | 2022-06-10 2031-06-10 | TENAX THERAPEUTICS INC. | TENX | Davidson Michael H. Director | 518,250 | $0 | 612,895 (Direct) | View |
| 2021-06-11 Exercise | 2021-06-15 4:34 pm | 2021-06-11 2021-06-11 | TENAX THERAPEUTICS INC. | TENX | Davidson Michael H. Director | 512 | $0 | 612,895 (Direct) | View |
Ownership | 2021-06-15 4:33 pm | N/A N/A | TENAX THERAPEUTICS INC. | TENX | Davidson Michael H. Director | 0 | $0 | 97,157 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-12 6:16 pm | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Davidson Michael H. Director | 37,735 | $0 | 144,323 (Direct) | View |
| 2020-07-28 Option Award | 2020-08-12 09:21 am | N/A N/A | CALADRIUS BIOSCIENCES INC. | CLBS | Davidson Michael H. Director | 51,063 | $2.35 | 51,063 (Direct) | View |